{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:18Z","timestamp":1761100998212},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1007\/bf03165290","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T03:57:27Z","timestamp":1254283047000},"page":"386-392","source":"Crossref","is-referenced-by-count":10,"title":["The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"76","author":[{"given":"Alois","family":"Gratwohl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03165290_CR1","first-page":"197","volume":"8","author":"A Gratwohl","year":"1991","unstructured":"Gratwohl A. Bone marrow transplantation activity in Europe 1990. Report from the European Group for Bone Marrow Transplantation (EBMT).Bone Marrow Transplant 1991;8:197\u2013201.","journal-title":"Bone Marrow Transplant"},{"key":"BF03165290_CR2","first-page":"123","volume":"10","author":"A Gratwohl","year":"1999","unstructured":"Gratwohl A, Baldomero H, Hermans J. Quantitative assessment of consensus on indications for blood or marrow transplantation in Europe 1995.Cancer Research Therapy and Control 1999;10:123\u2013144.","journal-title":"Cancer Research Therapy and Control"},{"key":"BF03165290_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.1365-2141.2002.03440.x","volume":"117","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilisation of haematopoietic stem cell transplants in Europe.Br J Haematol 2002; 117:451\u2013468.","journal-title":"Br J Haematol"},{"key":"BF03165290_CR4","volume-title":"Hematopoietic cell transplantation","year":"1998","unstructured":"Forman SJ, Blume KG, Thomas ED (Eds.): Hematopoietic cell transplantation, Second edition, Blackwell Scientific Publishers Inc., London, New York; 1998.","edition":"Second edition"},{"key":"BF03165290_CR5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1136\/bmj.321.7258.433","volume":"321","author":"AL Lennard","year":"2000","unstructured":"Lennard AL, Jackson GH. Stem cell transplantation.BMJ 2000;321:433\u2013437.","journal-title":"BMJ"},{"key":"BF03165290_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1701089","volume":"21","author":"JM Goldman","year":"1998","unstructured":"Goldman JM, Schmitz N, Niethammer D, Gratwohl A for the Accreditation Subcommittee of the EBMT. Special Report. Allogeneic and autologous transplantation for hematological diseases, solid tumours and immune disorders: current practice in Europe in 1998.Bone Marrow Transplant 1998;21:1\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"BF03165290_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199708073370602","volume":"337","author":"E Gluckman","year":"1997","unstructured":"Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors.N Engl J Med 1997;337:373\u2013381.","journal-title":"N Engl J Med"},{"key":"BF03165290_CR8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","volume":"344","author":"WI Bensinger","year":"2001","unstructured":"Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.N Engl J Med 2001;344:175\u2013181.","journal-title":"N Engl J Med"},{"key":"BF03165290_CR9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00062752-199704060-00008","volume":"4","author":"DL Confer","year":"1997","unstructured":"Confer DL. Unrelated marrow donor registries.Curr Opin Hematol 1997;4:408\u2013412.","journal-title":"Curr Opin Hematol"},{"key":"BF03165290_CR10","unstructured":"Schmitz N, Beksac M, Hasenclever D, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley JF, Gorin NC, Szer J, Bradstock K, Buzyn A, Clark P, Borkett K, Gratwohl A for the European Group for Blood and Marrow Transplanation (EBMT).Blood (in press)."},{"key":"BF03165290_CR11","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumour effects.Blood, 2001;97:3390\u20133400.","journal-title":"Blood"},{"key":"BF03165290_CR12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM200104053441402","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.N Engl J Med 2001;344:1038\u20131042.","journal-title":"N Engl J Med"},{"key":"BF03165290_CR13","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","volume":"344","author":"BJ Druker","year":"2001","unstructured":"Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.N Engl J Med 2001;344:1031\u20131037.","journal-title":"N Engl J Med"},{"key":"BF03165290_CR14","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0140-6736(02)07831-5","volume":"359","author":"A Gratwohl","year":"2002","unstructured":"Gratwohl A, Baldomero H, Urbano-Ispizua A. Hematopoietic stem cell transplantation and Gleevec: anticipation as driving force in decision making.Lancet 2002;359:712\u2013713.","journal-title":"Lancet"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165290.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03165290\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03165290","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:52:16Z","timestamp":1558479136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03165290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":14,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["BF03165290"],"URL":"https:\/\/doi.org\/10.1007\/bf03165290","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}